Paradox breaker BRAF inhibitors have comparable potency and MAPK pathway reactivation to encorafenib in BRAF mutant colorectal cancer

出版年份 2020 全文链接

标题

作者

关键词

出版物

Volume 11, Issue 34, Pages 3188-3197

出版商

Impact Journals, LLC

发表日期

2020-08-25

DOI

10.18632/oncotarget.27681

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now